RVL Pharmaceuticals plc Long-Term Debt
RVL Pharmaceuticals plc had Long-Term Debt of $63.60 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtNoncurrent · last filed 2023-08-14
- 2023-06-30: Long-term Debt, Excluding Current Maturities $63.60M.
- 2023-03-31: Long-term Debt, Excluding Current Maturities $67.13M.
- 2022-12-31: Long-term Debt, Excluding Current Maturities $75.00M.
- 2022-09-30: Long-term Debt, Excluding Current Maturities $75.00M.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2023-06-30 | $63.60M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $67.13M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $75.00M 10-K · filed 2023-03-20 | |
| 2022-09-30 | $75.00M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $55.00M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $55.00M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $55.00M 10-K · filed 2022-03-30 | |
| 2021-03-31 | $219.75M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $219.53M 10-Q · filed 2021-11-15 | |
| 2020-09-30 | $219.29M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $268.52M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $268.24M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $267.95M 8-K · filed 2021-09-08 | |
| 2019-09-30 | $267.66M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $267.37M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $267.08M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $266.80M 10-K · filed 2020-03-19 | $266.80M 10-K · filed 2019-03-28 |
| 2018-09-30 | $310.01M 10-Q · filed 2018-11-08 | |
| 2017-12-31 | $313.95M 8-K · filed 2019-12-20 |